Gene · 4738
Papers3,078
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,078
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Oxygen-regulated post-translation modifications as master signalling pathway in cells. | EMBO Rep | 2023 | 37877678 | PubTator, text mining | PubMed |
| Innovative preconditioning strategies for improving the therapeutic efficacy of extracellular vesicles derived from mesenchymal stem cells in gastrointestinal diseases. | Inflammopharmacology | 2023 | 37874430 | PubTator, text mining | PubMed |
| Catalysis of non-canonical protein ubiquitylation by the ARIH1 ubiquitin ligase. | Biochem J | 2023 | 37870100 | PubTator, text mining | PubMed |
| Elucidating the cellular determinants of targeted membrane protein degradation by lysosome-targeting chimeras. | Science | 2023 | 37856615 | PubTator, text mining | PubMed |
| Insights into the diverse mechanisms and effects of variant CUL3-induced familial hyperkalemic hypertension. | Cell Commun Signal | 2023 | 37845702 | PubTator, text mining | PubMed |
| Expanding PROTACtable genome universe of E3 ligases. | Nat Commun | 2023 | 37845222 | PubTator, text mining | PubMed |
| Persistence is key: unresolved immune dysfunction is lethal in both COVID-19 and non-COVID-19 sepsis. | Front Immunol | 2023 | 37822940 | PubTator, text mining | PubMed |
| Targeting menin: a promising therapeutic strategy for susceptible acute leukemia subtypes. | Signal Transduct Target Ther | 2023 | 37816719 | PubTator, text mining | PubMed |
| The herpesvirus UL49.5 protein hijacks a cellular C-degron pathway to drive TAP transporter degradation. | bioRxiv | 2023 | 37808699 | PubTator, text mining | PubMed |
| Neurodevelopmental disorders and microcephaly: how apoptosis, the cell cycle, tau and amyloid-β precursor protein APPly. | Front Mol Neurosci | 2023 | 37808474 | PubTator, text mining | PubMed |
| Post-translational modifications and their implications in cancer. | Front Oncol | 2023 | 37795435 | PubTator, text mining | PubMed |
| Genomic selection for survival under naturally occurring Saprolegnia oomycete infection in farmed European whitefish Coregonus lavaretus. | J Anim Sci | 2023 | 37777972 | PubTator, text mining | PubMed |
| Role of non-canonical post-translational modifications in gastrointestinal tumors. | Cancer Cell Int | 2023 | 37777749 | PubTator, text mining | PubMed |
| Activating transcription factor 3: A potential therapeutic target for inflammatory pulmonary diseases. | Immun Inflamm Dis | 2023 | 37773692 | PubTator, text mining | PubMed |
| Targeting cullin neddylation for cancer and fibrotic diseases. | Theranostics | 2023 | 37771770 | PubTator, text mining | PubMed |
| EBV-Associated Hub Genes as Potential Biomarkers for Predicting the Prognosis of Nasopharyngeal Carcinoma. | Viruses | 2023 | 37766321 | PubTator, text mining | PubMed |
| A CRISPR Screen of HIV Dependency Factors Reveals That CCNT1 Is Non-Essential in T Cells but Required for HIV-1 Reactivation from Latency. | Viruses | 2023 | 37766271 | PubTator, text mining | PubMed |
| ISGylation-independent protection of cell growth by USP18 following interferon stimulation. | Biochem J | 2023 | 37756534 | PubTator, text mining | PubMed |
| Elucidation of E3 ubiquitin ligase specificity through proteome-wide internal degron mapping. | Mol Cell | 2023 | 37738965 | PubTator, text mining | PubMed |
| Discovery of neddylation E2s inhibitors with therapeutic activity. | Oncogenesis | 2023 | 37717015 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4738/papers?page=13